Developments and Challenges for mAb-based Therapeutics

Author： Goswami Sumit   Wang Wei   Arakawa Tsutomu   Ohtake Satoshi  

Publisher： MDPI

E-ISSN： 2073-4468|2|3|452-500

ISSN： 2073-4468

Source： Antibodies, Vol.2, Iss.3, 2013-08, pp. : 452-500

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges

By Zhou Jiehua   Shum Ka-To   Burnett John C.   Rossi John J.  

Pharmaceuticals, Vol. 6, Iss. 1, 2013-01 ,pp. : 85-107

MDPI

Access to resources Recommend Favorite

High‐throughput mAb expression and purification platform based on transient CHO

By  

BIOTECHNOLOGY PROGRESS (ELECTRONIC), Vol. 31, Iss. 1, 2015-01 ,pp. : 239-247

John Wiley & Sons Inc

Access to resources Recommend Favorite

Applying Process-Based Models for Subsurface Flow Treatment Wetlands: Recent Developments and Challenges

By Langergraber Guenter  

Water, Vol. 9, Iss. 1, 2016-12 ,pp. : 5-5

MDPI

Access to resources Recommend Favorite

Melatonin-Based Therapeutics for Neuroprotection in Stroke

By Shinozuka Kazutaka   Staples Meaghan   Borlongan Cesar V.  

International Journal of Molecular Sciences, Vol. 14, Iss. 5, 2013-04 ,pp. : 8924-8947

MDPI

Access to resources Recommend Favorite

Developments in Brain Death: challenges to the standard concept

By David Lamb  

New Review of Bioethics, Vol. 1, Iss. 1, 2003-11 ,pp. : 159-168

Routledge Ltd

Access to resources Recommend Favorite